Tranexamic acid-associated seizures: Causes and treatment

Annals of Neurology

Volumn 79, Issue 1, 2016, Pages 18-26

  Lecker, Irene ^a   Wang, Dian Shi ^a   Whissell, Paul D ^b   Avramescu, Sinziana ^b,c   Mazer, C David ^a,b,c   Orser, Beverley A ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; GLYCINE RECEPTOR; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COMMUNITY; DRUG INDICATION; HUMAN; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; ANIMAL; CHEMICALLY INDUCED; SEIZURES;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; HUMANS; SEIZURES; TRANEXAMIC ACID;

EID: 84956574965     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24558     Document Type: Review

References (76)

1. Henry DA, Carless PA, Moxey AJ, et al.; Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;(3): CD001886.
2. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032.
3. Roberts I, Shakur H, Afolabi A, et al.; The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-1101.
4. Hoylaerts M, Lijnen HR, Collen D,. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981; 673: 75-85.
5. Iwamoto M,. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin. Thromb Diath Haemorrh 1975; 33: 573-585.
6. Thorsen S,. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids. Biochim Biophys Acta 1975; 393: 55-65.
7. McEvoy MD, Reeves ST, Reves JG, et al.; Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg 2007; 105: 949-962.
8. Berman M, Cardone D, Sharples L, et al.; Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients. Ann Thorac Surg 2010; 90: 1432-1436.
9. Bertholini DM, Butler CS,. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease. Anaesth Intensive Care 2000; 28: 199-201.
10. Bhat A, Bhowmik DM, Vibha D, et al.; Tranexamic acid overdosage-induced generalized seizure in renal failure. Saudi J Kidney Dis Transpl 2014; 25: 130-132.
11. Butala BP, Shah VR, Bhosale GP, et al.; Medication error: subarachnoid injection of tranexamic acid. Indian J Anaesth 2012; 56: 168-170.
12. de Leede-van der Maarl MG, Hilkens P, Bosch F,. The epileptogenic effect of tranexamic acid. J Neurol 1999; 246: 843.
13. Garcha PS, Mohan CV, Sharma RM,. Death after an inadvertent intrathecal injection of tranexamic acid. Anesth Analg 2007; 104: 241-242.
14. Ichikawa J, Kodaka M, Nishiyama K, et al.; A case of postoperative convulsive seizure following tranexamic acid infusion during aortic valve replacement. Masui 2013; 62: 186-189.
15. Kaabachi O, Eddhif M, Rais K, et al.; Inadvertent intrathecal injection of tranexamic acid. Saudi J Anaesth 2011; 5: 90-92.
16. Kalavrouziotis D, Voisine P, Mohammadi S, et al.; High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93: 148-154.
17. Keyl C, Uhl R, Beyersdorf F, et al.; High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 2011; 39: 114-121.
18. Koster A, Borgermann J, Zittermann A, et al.; Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013; 110: 34-40.
19. Mahmoud K, Ammar A,. Accidental intrathecal injection of tranexamic acid. Case Rep Anesthesiol 2012; 2012: 646028.
20. Manji RA, Grocott HP, Leake J, et al.; Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth 2012; 59: 6-13.
21. Martin K, Wiesner G, Breuer T, et al.; The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107: 1783-1790.
22. Merriman B, Mayson K, Sawka A, et al.; Postoperative seizure in a neurosurgical patient: should tranexamic acid be on the differential? Can J Anaesth 2013; 60: 506-507.
23. Mohseni K, Jafari A, Nobahar MR, et al.; Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia. Anesth Analg 2009; 108: 1984-1986.
24. Murkin JM, Falter F, Granton J, et al.; High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353.
25. Sander M, Spies CD, Martiny V, et al.; Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care 2010; 14: R148.
26. Sharma V, Katznelson R, Jerath A, et al.; The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 2014; 69: 124-130.
27. Wang CS, Yang CJ, Chen SC, et al.; Generalized convulsion resulted in hyperammonemia during treatment with tranexamic acid for hemoptysis. Ir J Med Sci 2011; 180: 761-763.
28. Wong JO, Yang SF, Tsai MH,. Accidental injection of tranexamic acid (Transamin) during spinal anesthesia. Ma Zui Xue Za Zhi 1988; 26: 249-252.
29. Yeh HM, Lau HP, Lin PL, et al.; Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology 2003; 98: 270-272.
30. Casati V, Romano A, Novelli E, et al.; Tranexamic acid for trauma. Lancet 2010; 376: 1049-1050.
31. Jimenez JJ, Iribarren JL, Brouard M, et al.; Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 2011; 6: 138.
32. Makhija N, Sarupria A, Kumar Choudhary S, et al.; Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety. J Cardiothorac Vasc Anesth 2013; 27: 1201-1207.
33. Rabinovici R, Heyman A, Kluger Y, et al.; Convulsions induced by aminocaproic acid infusion. DICP 1989; 23: 780-781.
34. Gofton TE, Chu MW, Norton L, et al.; A prospective observational study of seizures after cardiac surgery using continuous EEG monitoring. Neurocrit Care 2014; 21: 220-227.
35. Hunter GR, Young GB,. Seizures after cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25: 299-305.
36. Sindet-Pedersen S, Stenbjerg S,. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg 1986; 44: 703-707.
37. Wellington K, Wagstaff AJ,. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003; 63: 1417-1433.
38. Ducloy-Bouthors AS, Jude B, Duhamel A, et al.; High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117.
39. Rahman Z, Hoque R, Ali A, et al.; Blood conservation strategies for reducing peri-operative blood loss in open heart surgery. Mymensingh Med J 2011; 20: 45-53.
40. Sabovic M, Lavre J, Vujkovac B,. Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 2003; 18: 1388-1391.
41. Zufferey PJ, Miquet M, Quenet S, et al.; Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010; 104: 23-30.
42. Roberts I, Kawahara T,. Proposal for the inclusion of tranexamic acid (anti-fibrinolytic-lysine analogue) in the WHO model list of essential medicines. Geneva, Switzerland: World Health Organization, 2010.
43. Fergusson DA, Hebert PC, Mazer CD, et al.; A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331.
44. Pellegrini A, Giaretta D, Chemello R, et al.; Feline generalized epilepsy induced by tranexamic acid (AMCA). Epilepsia 1982; 23: 35-45.
45. Schlag MG, Hopf R, Zifko U, et al.; Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats. Acta Neurochir (Wien) 2002; 144: 63-69.
46. Yamaura A, Nakamura T, Makino H, et al,. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature. Eur Neurol 1980; 19: 77-84.
47. Lecker I, Wang DS, Romaschin AD, et al.; Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012; 122: 4654-4666.
48. Estrera AL, Sheinbaum R, Miller CC, et al.; Cerebrospinal fluid drainage during thoracic aortic repair: safety and current management. Ann Thorac Surg 2009; 88: 9-15.
49. Kratzer S, Irl H, Mattusch C, et al.; Tranexamic acid impairs γ-aminobutyric acid receptor type A-mediated synaptic transmission in the murine amygdala: a potential mechanism for drug-induced seizures? Anesthesiology 2014; 120: 639-649.
50. A receptors. FASEB J 1990; 4: 1469-1480.
51. A receptors. J Biol Chem 2012; 287: 40224-40231.
52. A receptors. Seizure 2013; 22: 589-600.
53. A receptors, anesthetics and anticonvulsants in brain development. CNS Neurol Disord Drug Targets 2008; 7: 211-224.
54. Sillito AM,. The effectiveness of bicuculline as an antagonist of GABA and visually evoked inhibition in the cat's striate cortex. J Physiol 1975; 250: 287-304.
55. Karkar KM, Thio LL, Yamada KA,. Effects of seven clinically important antiepileptic drugs on inhibitory glycine receptor currents in hippocampal neurons. Epilepsy Res 2004; 58: 27-35.
56. Lynch JW,. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 2004; 84: 1051-1095.
57. Furtmuller R, Schlag MG, Berger M, et al.; Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a γ-aminobutyric acid A receptor antagonistic effect. J Pharmacol Exp Ther 2002; 301: 168-173.
58. Chebib M, Johnston GA,. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem 2000; 43: 1427-1447.
59. A receptor channels. Annu Rev Neurosci 1994; 17: 569-602.
60. A receptors responsible for tonic and phasic conductances. Neurochem Res 2001; 26: 907-913.
61. Lynch JW,. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 2009; 56: 303-309.
62. A receptors. Nat Rev Neurosci 2005; 6: 215-229.
63. Parker AJ, Lee JB, Redman J, et al.; Strychnine poisoning: gone but not forgotten. Emerg Med J 2011; 28: 84.
64. Young AB, Snyder SH,. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A 1973; 70: 2832-2836.
65. Downie DL, Hall AC, Lieb WR, et al.; Effects of inhalational general anaesthetics on native glycine receptors in rat medullary neurones and recombinant glycine receptors in Xenopus oocytes. Br J Pharmacol 1996; 118: 493-502.
66. Hales TG, Lambert JJ,. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol 1991; 104: 619-628.
67. Belelli D, Callachan H, Hill-Venning C, et al.; Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes. Br J Pharmacol 1996; 118: 563-576.
68. A receptor subtypes and addiction. Trends Neurosci 2011; 34: 188-197.
69. Curtis DR, Game CJ, Lodge D,. Benzodiazepines and central glycine receptors. Br J Pharmacol 1976; 56: 307-311.
70. Hui AC, Wong TY, Chow KM, et al.; Multifocal myoclonus secondary to tranexamic acid. J Neurol Neurosurg Psychiatry 2003; 74: 547.
71. Bojko B, Vuckovic D, Cudjoe E, et al.; Determination of tranexamic acid concentration by solid phase microextraction and liquid chromatography-tandem mass spectrometry: first step to in vivo analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879: 3781-3787.
72. Sharma V, Fan J, Jerath A, et al.; Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia 2012; 67: 1242-1250.
73. Fox MA,. Tranexamic acid: how much is enough? Anesth Analg 2010; 111: 580-581.
74. Merino JG, Latour LL, Tso A, et al.; Blood-brain barrier disruption after cardiac surgery. Am J Neuroradiol 2013; 34: 518-523.
75. Dubber AH, McNicol GP, Douglas AS,. Amino methyl cyclohexane carboxylic acid (AMCHA), a new synthetic fibrinolytic inhibitor. Br J Haematol 1965; 11: 237-245.
76. Dubber AH, McNicol GP, Douglas AS, et al.; Some properties of the antifibrinolytically active isomer of amino-methylcyclohexane carboxylic acid. Lancet 1964; 2: 1317-1319.